Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19 ... which could lead to treatments for the cognitive symptoms of Parkinson's ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.